Advertisement

Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort

      Abstract

      Purpose

      The French National Cancer Institute has developed, in partnership with the French National Authority for Health, breast cancer-specific Care Quality, and Safety Indicators (BC QIs). With regard to the most common form of cancer, our aim is to support local and national quality initiatives, to improve BC pathways and outcomes, reduce heterogeneity of practice and regional inequities. In this study, we measure the BC QIs available in the French National medico-administrative cancer database, the French Cancer Cohort, for 2018.

      Materials and Methods

      BC QIs are developed according to the RAND method. QIs are based on good clinical practice and care pathway recommendations. QI computation should be automatable without any additional workload for data collection. They will be published annually for all stakeholders, and especially hospitals.

      Results

      Finally, ten feasible and pertinent QIs were selected. In France, BC care was found to be close to compliance with most QIs: proportion of patients undergoing biopsy prior to first treatment (94.5%), proportion of patients undergoing adjuvant radiotherapy after breast-conserving surgery for BC (94.5%), proportion of women undergoing radiotherapy within 12 weeks after surgery and without chemotherapy (86.2%), proportion of DCIS patients undergoing immediate breast reconstruction (54.3%) and proportion of women with NMIBC undergoing breast reintervention (14.4%). However, some are still far from their recommended rate. In particular, some QIs vary considerably from one region, or one patient, to another.

      Conclusion

      Each result needs to be analyzed locally to find care quality leverage. This will strengthen transparency actions aimed at the public.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Institut national du cancer, ministère des Affaires sociales et de la Santé, et ministère de l'Enseignement supérieur et de la Recherche. 2014. Plan cancer 2014-2019 http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Plan-Cancer-2014-2019.

        • Defossez G
        • Le Guyader-Peyrou S
        • Uhry Z
        • et al.
        National estimates of cancer incidence and mortality in metropolitan France between 1990 and 2018. Overview.
        Santé publique France, Saint-Maurice2019 (20p)
        • Donabedian
        Evaluating the quality of medical care.
        Milbank Memorial Fund Quart. 1966; 44 (Suppl): 166-206
        • OECD
        Improving Value in Health Care: Measuring Quality, OECD Health Policy Studies.
        Editions OECD, Paris2010https://doi.org/10.1787/9789264094819-en (https://doi.org/)
      2. Haute Autorité de Santé. Le suivi d'indicateurs de qualité et des soins - Fiche méthode. 2014. Available on: http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-2/suivi_indicateurs_qualite_fiche_technique_2013_01_31.pdf

        • Laronga C
        • Gray JE
        • Siegel EM
        • et al.
        Florida initiative for quality cancer care: improvements in breast cancer quality indicators during a 3-year interval.
        J Am Coll Surg. 2014; 219: 638-645https://doi.org/10.1016/j.jamcollsurg.2014.03.063
        • Del Turco MR
        • Ponti A
        • Bick U
        • et al.
        Quality indicators in breast cancer care.
        Eur J Cancer. 2010; 46 (Sep;Epub 2010 Jul 31. PMID: 20675120): 2344-2356https://doi.org/10.1016/j.ejca.2010.06.119
        • Biganzoli L
        • Marotti L
        • Hart CD
        • et al.
        Quality indicators in breast cancer care: an update from the EUSOMA working group.
        Eur J Cancer. 2017; 86 (NovEpub 2017 Sep 28. PMID: 28963914): 59-81https://doi.org/10.1016/j.ejca.2017.08.017
        • Kiderlen M
        • Ponti A
        • Tomatis M
        • et al.
        Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.
        Eur J Cancer. 2015; 51 (JulEpub 2015 Apr 16. PMID: 25892645): 1221-1230https://doi.org/10.1016/j.ejca.2015.03.013
      3. Fitch K, Berntein SJ, Aguilar MD, et al. The RAND/UCLA Appropriateness Method User's Manual. 2001. Available on: http://www.rand.org/pubs/monograph_reports/MR1269.html

      4. Institut National du Cancer. Cancer du sein: Indicateurs de qualité et de sécurité des soins, Collection les Données, mars 2019.

        • Bousquet PJ
        • Lefeuvre D
        • Tuppin P
        • BenDiane MK
        • Rocchi M
        • Bouée-Benhamiche E
        • et al.
        Cancer care and public health policy evaluations in France: usefulness of the national cancer cohort.
        PLoS One. 2018; 13 (Oct 31PMID: 30379946; PMCID: PMC6209307)e0206448https://doi.org/10.1371/journal.pone.0206448
        • Tuppin P
        • Rudant J
        • Constantinou P
        • et al.
        Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
        Rev Epidemiol Sante Publique. 2017; 65 (OctSupplEpub 2017 Jul 27. PMID: 28756037): S149-S167https://doi.org/10.1016/j.respe.2017.05.004
        • Hartmann-Johnsen OJ
        • Kåresen R
        • Schlichting E
        • Naume B
        • Nygård JF.
        Using clinical cancer registry data for estimation of quality indicators: results from the Norwegian breast cancer registry.
        Int J Med Inform. 2019; 125 (MayEpub 2019 Mar 9. PMID: 30914174): 102-109https://doi.org/10.1016/j.ijmedinf.2019.03.004
        • Cowppli-Bony A
        • Trétarre B
        • Marrer E
        • et al.
        Compliance with clinical guidelines for breast cancer management: a population-based study of quality-of-care indicators in France.
        PLoS One. 2019; 14 (Oct 23PMID: 31644603; PMCID: PMC6808419)e0224275https://doi.org/10.1371/journal.pone.0224275
        • van Bommel ACM
        • Spronk PER
        • Vrancken Peeters M-JTFD
        • et al.
        Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The National NABON Breast Cancer Audit.
        J Surg Oncol. 2017; 115: 243https://doi.org/10.1002/jso.24516
        • van Dam PA
        • Tomatis M
        • Marotti L
        • et al.
        The effect of EUSOMA certification on quality of breast cancer care.
        Eur J Surg Oncol. 2015; 41 (OctEpub 2015 Jun 24. PMID: 26278019): 1423-1429https://doi.org/10.1016/j.ejso.2015.06.006
        • Pons-Tostivint E
        • Daubisse-Marliac L
        • Grosclaude P
        • et al.
        Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: a French regional multicenter study.
        Breast. 2019; 46 (AugEpub 2019 Jun 7. PMID: 31226572): 170-177https://doi.org/10.1016/j.breast.2019.06.001
        • Vos EL
        • Koppert LB
        • Jager A
        • Vrancken Peeters MTFD
        • Siesling S
        • Lingsma HF
        From multiple quality indicators of breast cancer care toward hospital variation of a summary measure.
        Value Health. 2020; 23 (SepEpub 2020 Aug 15. PMID: 32940238): 1200-1209https://doi.org/10.1016/j.jval.2020.05.011
        • Sacerdote C
        • Bordon R
        • Pitarella S
        • et al.
        Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in Italy.
        BMC Health Serv Res. 2013; 13 (PMID: 23351327; PMCID: PMC3566978): 28https://doi.org/10.1186/1472-6963-13-28
        • Guarneri V
        • Pronzato P
        • Bertetto O
        • et al.
        Use of electronic administrative databases to measure quality indicators of breast cancer care: experience of five regional oncology networks in Italy.
        JCO Oncol Pract. 2020; 16 (FebEpub 2019 Dec 19. PMID: 31855497; PMCID: PMC7025426): e211-e220https://doi.org/10.1200/JOP.19.00466
        • Ponti A
        • Mano MP
        • Tomatis M
        • et al.
        Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy, 2011-2012.
        Epidemiol Prev. 2015; 39 (May-JunSuppl 1PMID: 26405775): 40-47
        • Héquet D
        • Huchon C
        • Baffert S
        • et al.
        Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.
        Br J Cancer. 2017; 116 (Epub 2017 Apr 25. PMID: 28441385; PMCID: PMC5520093): 1394-1401https://doi.org/10.1038/bjc.2017.114
        • Lefeuvre D
        • Le Bihan-Benjamin C
        • Pauporté I
        • Medioni J
        • Bousquet PJ
        French medico-administrative data to identify the care pathways of women with breast cancer.
        Clin Breast Cancer. 2017; 17 (JulEpub 2017 Jan 27. PMID: 28237608): e191-e197https://doi.org/10.1016/j.clbc.2017.01.008
        • Selove R
        • Kilbourne B
        • Fadden MK
        • et al.
        Time from screening mammography to biopsy and from biopsy to breast cancer treatment among Black and White, women Medicare beneficiaries not participating in a health maintenance organization.
        Women's Health Issues. 2016; 26: 642-647https://doi.org/10.1016/j.whi.2016.09.003
      5. CNAMTS. Améliorer la qualité du système de santé et maîtriser les dépenses. Propositions de l'Assurance Maladie pour 2015. Rapport au ministre chargé de la Sécurité sociale et au Parlement sur l'évolution des charges et des produits de l'Assurance Maladie au titre de 2015 (loi du 13 août 2004).

        • Régis C
        • Le J
        • Chauvet M-P
        • Le Deley M-C
        • Le Teuff G
        Variations in the breast reconstruction rate in France: a nationwide study of 19,466 patients based on the French medico-administrative database.
        Breast. 2018; 42: 74-80https://doi.org/10.1016/j.breast.2018.07.009
        • Iwamoto M
        • Nakamura F
        • Higashi T.
        Monitoring and evaluating the quality of cancer care in Japan using administrative claims data.
        Cancer Sci. 2016; 107: 68https://doi.org/10.1111/cas.12837
        • Powis M
        • Sutradhar R
        • Gonzalez A
        • et al.
        Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.
        Cancer. 2017; 123 (Oct 1Epub 2017 Jul 5. PMID: 28678343): 3772-3780https://doi.org/10.1002/cncr.30804
        • Stordeur S
        • Vrijens F
        • Devriese S
        • Beirens K
        • Van Eycken E
        • Vlayen J.
        Developing and measuring a set of process and outcome indicators for breast cancer.
        Breast. 2012; 21 (JunEpub 2011 Nov 6. PMID: 22056787): 253-260https://doi.org/10.1016/j.breast.2011.10.003
        • Bleicher RJ
        • Chang C
        • Wang CE
        • et al.
        Treatment delays from transfers of care and their impact on breast cancer quality measures.
        Breast Cancer Res Treat. 2019; 173 (FebEpub 2018 Nov 15. PMID: 30443881): 603-617https://doi.org/10.1007/s10549-018-5046-x